Cargando…
Galectin-3 predicts response and outcomes after cardiac resynchronization therapy
BACKGROUND: Cardiac resynchronization therapy (CRT) reduces symptoms, morbidity and mortality in chronic heart failure patients with wide QRS complexes. However, approximately one third of CRT patients are non-responders. Myocardial fibrosis is known to be associated with absence of response. We sou...
Autores principales: | Andre, Clémentine, Piver, Eric, Perault, Romain, Bisson, Arnaud, Pucheux, Julien, Vermes, Emmanuelle, Pierre, Bertrand, Fauchier, Laurent, Babuty, Dominique, Clementy, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215623/ https://www.ncbi.nlm.nih.gov/pubmed/30390680 http://dx.doi.org/10.1186/s12967-018-1675-4 |
Ejemplares similares
-
Localization of Left Ventricular Lead Electrodes in Relation to Myocardial Scar in Patients Undergoing Cardiac Resynchronization Therapy
por: Bisson, Arnaud, et al.
Publicado: (2018) -
Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
por: Clementy, Nicolas, et al.
Publicado: (2018) -
Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure
por: Clementy, Nicolas, et al.
Publicado: (2018) -
Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation
por: Clementy, Nicolas, et al.
Publicado: (2016) -
Benefits of an early management of palpitations
por: Clementy, Nicolas, et al.
Publicado: (2018)